ANL
Price
$10.85Alerts
Change
+$0.89 (+8.94%)
Updated
Nov 11 closing price
Capitalization
662.01M
20 days until earnings call
Intraday BUY SELL Signals
MSLE
Price
$6.75Alerts
Change
-$0.34 (-4.80%)
Updated
Nov 11 closing price
Capitalization
152.55M
One day until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ANL vs MSLE

ANL vs MSLE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ANL vs. MSLE commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANL is a Buy and MSLE is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ANL with price predictions
Nov 11, 2026

ANL in upward trend: price may jump up because it broke its lower Bollinger Band on October 13, 2026

ANL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 19 of 21 cases where ANL's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ANL's RSI Indicator exited the oversold zone, 13 of 15 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 24 of 30 cases where ANL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.

The Momentum Indicator moved above the 0 level on November 11, 2026. You may want to consider a long position or call options on ANL as a result. In 56 of 72 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.

The Moving Average Convergence Divergence (MACD) for ANL just turned positive on November 06, 2026. Looking at past instances where ANL's MACD turned positive, the stock continued to rise in 22 of 26 cases over the following month. The odds of a continued upward trend are 85%.

Following a +15.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where ANL advanced for three days, in 121 of 148 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

Bearish Trend Analysis

ANL moved below its 50-day moving average on October 12, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ANL crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for ANL entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.082) is normal, around the industry mean (3.498). P/E Ratio (-15.576) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (33.784) is also within normal values, averaging (440.869).

The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. ANL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
a Summary for MSLE with price predictions
Nov 11, 2026

Momentum Indicator for MSLE turns positive, indicating new upward trend

MSLE saw its Momentum Indicator move above the 0 level on November 06, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 100 similar instances where the indicator turned positive. In 80 of the 100 cases, the stock moved higher in the following days. The odds of a move higher are at 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MSLE's RSI Indicator exited the oversold zone, 13 of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 65%.

The Moving Average Convergence Divergence (MACD) for MSLE just turned positive on October 27, 2026. Looking at past instances where MSLE's MACD turned positive, the stock continued to rise in 33 of 47 cases over the following month. The odds of a continued upward trend are 70%.

Following a +17.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where MSLE advanced for three days, in 93 of 118 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 37 of 53 cases where MSLE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 70%.

The 50-day moving average for MSLE moved below the 200-day moving average on November 04, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MSLE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.

MSLE broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MSLE entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. MSLE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 35 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.546) is normal, around the industry mean (3.498). P/E Ratio (-3.687) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MSLE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

FUNDAMENTALS RATINGS
MSLE: Fundamental Ratings
MSLE
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANLMSLE
RSI
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
65%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
70%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
70%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 1 day ago
77%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
80%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
74%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (ANL: $9.96 vs. MSLE: $7.09)
Brand notoriety: ANL and MSLE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANL: 131% vs. MSLE: 21%
Market capitalization -- ANL: $662.01M vs. MSLE: $152.55M
ANL [@Biotechnology] is valued at $662.01M. MSLE’s [@Biotechnology] market capitalization is $152.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANL’s FA Score shows that 2 FA rating(s) are green while MSLE’s FA Score has 0 green FA rating(s).

  • ANL’s FA Score: 2 green, 3 red.
  • MSLE’s FA Score: 0 green, 5 red.
According to our system of comparison, ANL is a better buy in the long-term than MSLE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANL’s TA Score shows that 5 TA indicator(s) are bullish while MSLE’s TA Score has 4 bullish TA indicator(s).

  • ANL’s TA Score: 5 bullish, 5 bearish.
  • MSLE’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ANL is a better buy in the short-term than MSLE.

Price Growth

ANL (@Biotechnology) experienced а +3.97% price change this week, while MSLE (@Biotechnology) price change was +11.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was -2.72%, and the average quarterly price growth was -13.41%.

Reported Earning Dates

ANL is expected to report earnings on Dec 02, 2026.

MSLE is expected to report earnings on Nov 13, 2026.

Industries' Descriptions

@Biotechnology (+4.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

ANL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANL has been loosely correlated with REVB. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if ANL jumps, then REVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANL
1D Price
Change %
ANL100%
+8.94%
REVB - ANL
33%
Loosely correlated
+5.96%
ALXO - ANL
25%
Poorly correlated
+0.90%
HYPD - ANL
23%
Poorly correlated
+4.63%
VIVS - ANL
23%
Poorly correlated
+19.47%
MOLN - ANL
23%
Poorly correlated
-6.77%
More

MSLE and

Correlation & Price change

A.I.dvisor indicates that over the last year, MSLE has been loosely correlated with ANL. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MSLE jumps, then ANL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MSLE
1D Price
Change %
MSLE100%
-4.80%
ANL - MSLE
40%
Loosely correlated
+8.94%
RVMD - MSLE
33%
Poorly correlated
-6.40%
BNTX - MSLE
29%
Poorly correlated
+0.50%
IPSC - MSLE
27%
Poorly correlated
+3.57%
ACHV - MSLE
26%
Poorly correlated
N/A
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TAOP0.340.03
+11.31%
Taoping Inc
IIIN27.950.46
+1.67%
Insteel Industries
HOVR1.360.01
+0.74%
New Horizon Aircraft Ltd
REG76.18-0.36
-0.47%
Regency Centers Corp
MD31.45-0.17
-0.54%
Pediatrix Medical Group